This article's use of external links may not follow Wikipedia's policies or guidelines. (October 2012) (Learn how and when to remove this template message)
A single-nucleotide polymorphism, often abbreviated to SNP (//; plural //), is a variation in a single nucleotide that occurs at a specific position in the genome, where each variation is present to some appreciable degree within a population (e.g. > 1%).
For example, at a specific base position in the human genome, the C nucleotide may appear in most individuals, but in a minority of individuals, the position is occupied by an A. This means that there is a SNP at this specific position, and the two possible nucleotide variations – C or A – are said to be alleles for this position.
SNPs underlie differences in our susceptibility to a wide range of diseases (e.g. – sickle-cell anemia, β-thalassemia and cystic fibrosis result from SNPs). The severity of illness and the way the body responds to treatments are also manifestations of genetic variations. For example, a single-base mutation in the APOE (apolipoprotein E) gene is associated with a lower risk for Alzheimer's disease.
A single-nucleotide variant (SNV) is a variation in a single nucleotide without any limitations of frequency and may arise in somatic cells. A somatic single-nucleotide variation (e.g., caused by cancer) may also be called a single-nucleotide alteration.
- 1 Types
- 2 Applications
- 3 Frequency
- 4 Importance
- 5 Examples
- 6 Databases
- 7 Nomenclature
- 8 SNP analysis
- 9 Programs for prediction of SNP effects
- 10 See also
- 11 Notes
- 12 References
- 13 External links
|Types of SNPs|
Single-nucleotide polymorphisms may fall within coding sequences of genes, non-coding regions of genes, or in the intergenic regions (regions between genes). SNPs within a coding sequence do not necessarily change the amino acid sequence of the protein that is produced, due to degeneracy of the genetic code.
SNPs in the coding region are of two types: synonymous and nonsynonymous SNPs. Synonymous SNPs do not affect the protein sequence, while nonsynonymous SNPs change the amino acid sequence of protein. The nonsynonymous SNPs are of two types: missense and nonsense.
SNPs that are not in protein-coding regions may still affect gene splicing, transcription factor binding, messenger RNA degradation, or the sequence of noncoding RNA. Gene expression affected by this type of SNP is referred to as an eSNP (expression SNP) and may be upstream or downstream from the gene.
- Association studies can determine whether a genetic variant is associated with a disease or trait.
- A tag SNP is a representative single-nucleotide polymorphism (SNP's) in a region of the genome with high linkage disequilibrium (the non-random association of alleles at two or more loci). Tag SNPs are useful in whole-genome SNP association studies, in which hundreds of thousands of SNPs across the entire genome are genotyped.
- Haplotype mapping: sets of alleles or DNA sequences can be clustered so that a single SNP can identify many linked SNPs.
- Linkage disequilibrium (LD), a term used in population genetics, indicates non-random association of alleles at two or more loci, not necessarily on the same chromosome. It refers to the phenomenon that SNP allele or DNA sequence that are close together in the genome tend to be inherited together. LD is affected by two parameters: 1) The distance between the SNPs [the larger the distance, the lower the LD]. 2) Recombination rate [the lower the recombination rate, the higher the LD].
More than 84 million SNPs have been found across humans from multiple populations. A typical genome differs from the reference human genome at 4 to 5 million sites, most of which (more than 99.9%) consist of SNPs and short indels.
Within a genome
The genomic distribution of SNPs is not homogenous; SNPs occur in non-coding regions more frequently than in coding regions or, in general, where natural selection is acting and "fixing" the allele (eliminating other variants) of the SNP that constitutes the most favorable genetic adaptation. Other factors, like genetic recombination and mutation rate, can also determine SNP density.
SNP density can be predicted by the presence of microsatellites: AT microsatellites in particular are potent predictors of SNP density, with long (AT)(n) repeat tracts tending to be found in regions of significantly reduced SNP density and low GC content.
Within a population
There are variations between human populations, so a SNP allele that is common in one geographical or ethnic group may be much rarer in another. Within a population, SNPs can be assigned a minor allele frequency — the lowest allele frequency at a locus that is observed in a particular population. This is simply the lesser of the two allele frequencies for single-nucleotide polymorphisms.
Variations in the DNA sequences of humans can affect how humans develop diseases and respond to pathogens, chemicals, drugs, vaccines, and other agents. SNPs are also critical for personalized medicine. Examples include biomedical research, forensics, pharmacogenetics, and disease causation, as outlined below.
SNPs' greatest importance in biomedical research is for comparing regions of the genome between cohorts (such as with matched cohorts with and without a disease) in genome-wide association studies. SNPs have been used in genome-wide association studies as high-resolution markers in gene mapping related to diseases or normal traits. SNPs without an observable impact on the phenotype (so called silent mutations) are still useful as genetic markers in genome-wide association studies, because of their quantity and the stable inheritance over generations.
This section needs expansion. You can help by adding to it. (November 2015)
SNPs were used initially for matching a forensic DNA sample to a suspect but it has been phased out with development of STR-based DNA fingerprinting techniques. In the future SNPs may be used in forensics for some phenotypic clues like eye color, hair color, ethnicity, etc. Kidd et al. have demonstrated that a panel of 19 SNPs can identify the ethnic group with good probability of match (Pm = 10^-7) in 40 population groups studied. One example of how this might potentially be useful is in the area of artistic reconstruction of possible premortem appearances of skeletonized remains of unknown individuals. Although a facial reconstruction can be fairly accurate based strictly upon anthropological features, other data that might allow a more accurate representation include eye color, skin color, hair color, etc.
In a situation with a low amount of forensic sample or a degraded sample, SNP methods can be a good alternative to STR methods due to the abundance of potential markers, amenability to automation, and potential reduction of required fragment length to only 60-80 bp. In the absence of a STR match in DNA profile database; different SNPs can be used to get clues regarding ethnicity, phenotype, lineage, and even identity.
Some SNPs are associated with the metabolism of different drugs. The association of a wide range of human diseases like cancer, infectious diseases (AIDS, leprosy, hepatitis, etc.) autoimmune, neuropsychiatric and many other diseases with different SNPs can be made as relevant pharmacogenomic targets for drug therapy.
A single SNP may cause a Mendelian disease, though for complex diseases, SNPs do not usually function individually, rather, they work in coordination with other SNPs to manifest a disease condition as has been seen in Osteoporosis. One of the earliest successes in this field was finding a single base mutation in the non-coding region of the APOC3 (apolipoprotein C3 gene) that associated with higher risks of hypertriglyceridemia and atherosclerosis.
All types of SNPs can have an observable phenotype or can result in disease:
- SNPs in non-coding regions can manifest in a higher risk of cancer, and may affect mRNA structure and disease susceptibility. Non-coding SNPs can also alter the level of expression of a gene, as an eQTL (expression quantitative trait locus).
- SNPs in coding regions:
- synonymous substitutions by definition do not result in a change of amino acid in the protein, but still can affect its function in other ways. An example would be a seemingly silent mutation in the multidrug resistance gene 1 (MDR1), which codes for a cellular membrane pump that expels drugs from the cell, can slow down translation and allow the peptide chain to fold into an unusual conformation, causing the mutant pump to be less functional (in MDR1 protein e.g. C1236T polymorphism changes a GGC codon to GGT at amino acid position 412 of the polypeptide (both encode glycine) and the C3435T polymorphism changes ATC to ATT at position 1145 (both encode isoleucine)).
- nonsynonymous substitutions:
- missense – single change in the base results in change in amino acid of protein and its malfunction which leads to disease (e.g. c.1580G>T SNP in LMNA gene – position 1580 (nt) in the DNA sequence (CGT codon) causing the guanine to be replaced with the thymine, yielding CTT codon in the DNA sequence, results at the protein level in the replacement of the arginine by the leucine in the position 527, at the phenotype level this manifests in overlapping mandibuloacral dysplasia and progeria syndrome)
- nonsense – point mutation in a sequence of DNA that results in a premature stop codon, or a nonsense codon in the transcribed mRNA, and in a truncated, incomplete, and usually nonfunctional protein product (e.g. Cystic fibrosis caused by the G542X mutation in the cystic fibrosis transmembrane conductance regulator gene).
- rs6311 and rs6313 are SNPs in the Serotonin 5-HT2A receptor gene on human chromosome 13.
- A SNP in the F5 gene causes Factor V Leiden thrombophilia.
- rs3091244 is an example of a triallelic SNP in the CRP gene on human chromosome 1.
- TAS2R38 codes for PTC tasting ability, and contains 6 annotated SNPs.
- rs148649884 and rs138055828 in the FCN1 gene encoding M-ficolin crippled the ligand-binding capability of the recombinant M-ficolin.
- An intronic SNP in DNA mismatch repair gene PMS2 (rs1059060, Ser775Asn) is associated with increased sperm DNA damage and risk of male infertility.
As there are for genes, bioinformatics databases exist for SNPs.
- dbSNP is a SNP database from the National Center for Biotechnology Information (NCBI). As of June 8, 2015[update], dbSNP listed 149,735,377 SNPs in humans.
- Kaviar is a compendium of SNPs from multiple data sources including dbSNP.
- SNPedia is a wiki-style database supporting personal genome annotation, interpretation and analysis.
- The OMIM database describes the association between polymorphisms and diseases (e.g., gives diseases in text form)
- dbSAP – single amino-acid polymorphism database for protein variation detection
- The Human Gene Mutation Database provides gene mutations causing or associated with human inherited diseases and functional SNPs
- The International HapMap Project, where researchers are identifying Tag SNPs to be able to determine the collection of haplotypes present in each subject.
- GWAS Central allows users to visually interrogate the actual summary-level association data in one or more genome-wide association studies.
The International SNP Map working group mapped the sequence flanking each SNP by alignment to the genomic sequence of large-insert clones in Genebank. These alignments were converted to chromosomal coordinates that is shown in Table 1. This list has greatly increased since, with, for instance, the Kaviar database now listing 162 million single nucleotide variants (SNVs).
|Chromosome||Length(bp)||All SNPs||TSC SNPs|
|Total SNPs||kb per SNP||Total SNPs||kb per SNP|
The nomenclature for SNPs can be confusing: several variations can exist for an individual SNP and consensus has not yet been achieved. One approach is to write SNPs with a prefix, period and "greater than" sign showing the wild-type and altered nucleotide or amino acid; for example, c.76A>T. SNPs are frequently referred to by their dbSNP rs number, as in the examples above.
SNPs are usually biallelic and thus easily assayed. Analytical methods to discover novel SNPs and detect known SNPs include:
- DNA sequencing;
- capillary electrophoresis;
- mass spectrometry;
- single-strand conformation polymorphism (SSCP);
- single-base extension;
- electrochemical analysis;
- denaturating HPLC and gel electrophoresis;
- restriction fragment length polymorphism;
- hybridization analysis;
Programs for prediction of SNP effects
An important group of SNPs are those that corresponds to missense mutations causing amino acid change on protein level. Point mutation of particular residue can have different effect on protein function (from no effect to complete disruption its function). Usually, change in amino acids with similar size and physico-chemical properties (e.g. substitution from leucine to valine) has mild effect, and opposite. Similarly, if SNP disrupts secondary structure elements (e.g. substitution to proline in alpha helix region) such mutation usually may affect whole protein structure and function. Using those simple and many other machine learning derived rules a group of programs for the prediction of SNP effect was developed:
- SIFTThis program provides insight into how a laboratory induced missense or nonsynonymous mutation will affect protein function based on physical properties of the amino acid and sequence homology.
- MutationTaster: official website
- Variant Effect Predictor from the Ensembl project
- SNPVizThis program provides a 3D representation of the protein affected, highlighting the amino acid change so doctors can determine pathogenicity of the mutant protein.
- "single-nucleotide polymorphism / SNP | Learn Science at Scitable". www.nature.com. Archived from the original on 2015-11-10. Retrieved 2015-11-13.
- Ingram, V. M. (13 October 1956). "A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin". Nature. 178 (4537): 792–794. doi:10.1038/178792a0. PMID 13369537.
- Chang, J. C.; Kan, Y. W. (June 1979). "Beta 0 thalassemia, a nonsense mutation in man". Proceedings of the National Academy of Sciences of the United States of America. 76 (6): 2886–2889. doi:10.1073/pnas.76.6.2886. PMC 383714. PMID 88735.
- Hamosh, A.; King, T. M.; Rosenstein, B. J.; Corey, M.; Levison, H.; Durie, P.; Tsui, L. C.; McIntosh, I.; Keston, M.; Brock, D. J.; Macek, M.; Zemková, D.; Krásničanová, H.; Vávrová, V.; Macek, M.; Golder, N.; Schwarz, M. J.; Super, M.; Watson, E. K.; Williams, C.; Bush, A.; O'Mahoney, S. M.; Humphries, P.; Dearce, M. A.; Reis, A.; Bürger, J.; Stuhrmann, M.; Schmidtke, J.; Wulbrand, U.; Dörk, T. (August 1992). "Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus". American Journal of Human Genetics. 51 (2): 245–250. PMC 1682672. PMID 1379413.
- Wolf, A. B.; Caselli, R. J.; Reiman, E. M.; Valla, J. (April 2013). "APOE and neuroenergetics: An emerging paradigm in Alzheimer's disease". Neurobiology of Aging. 34 (4): 1007–17. doi:10.1016/j.neurobiolaging.2012.10.011. PMC 3545040. PMID 23159550.
- Zhang, Kui; Qin, Zhaohui S.; Liu, Jun S.; Chen, Ting; Waterman, Michael S.; Sun, Fengzhu (1 May 2004). "Haplotype Block Partitioning and Tag SNP Selection Using Genotype Data and Their Applications to Association Studies". Genome Research. 14 (5): 908–916. doi:10.1101/gr.1837404. PMID 15078859. Archived from the original on 8 May 2018. Retrieved 8 May 2018 – via genome.cshlp.org.
- Gupta, P.K.; Roy, J.K.; Prasad, M. (25 February 2001). "Single nucleotide polymorphisms: a new paradigm for molecular marker technology and DNA polymorphism detection with emphasis on their use in plants". Current Science. 80 (4): 524–535. Archived from the original on 13 February 2017.
- The 1000 Genomes Project Consortium (October 2015). "A global reference for human genetic variation". Nature. 526: 68–74. doi:10.1038/nature15393.
- Barreiro L. B.; Laval G.; Quach H.; Patin E.; Quintana-Murci L. (March 2008). "Natural selection has driven population differentiation in modern humans". Nature Genetics. 40 (3): 340–345. doi:10.1038/ng.78. PMID 18246066.
- Nachman, Michael W. (September 2001). "Single-nucleotide polymorphisms and recombination rate in humans". Trends in Genetics. 17 (9): 481–485. doi:10.1016/S0168-9525(01)02409-X. PMID 11525814.
- M. A. Varela; W. Amos (March 2010). "Heterogeneous distribution of SNPs in the human genome: Microsatellites as predictors of nucleotide diversity and divergence". Genomics. 95 (3): 151–159. doi:10.1016/j.ygeno.2009.12.003. PMID 20026267.
- Carlson, Bruce (15 June 2008). "SNPs — A Shortcut to Personalized Medicine". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc. 28 (12). Archived from the original on 26 December 2010. Retrieved 2008-07-06.
(subtitle) Medical applications are where the market's growth is expected
- Thomas, P. E.; Klinger, R.; Furlong, L. I.; Hofmann-Apitius, M.; Friedrich, C. M. (2011). "Challenges in the association of human single-nucleotide polymorphism mentions with unique database identifiers". BMC Bioinformatics. 12: S4. doi:10.1186/1471-2105-12-S4-S4. PMC 3194196. PMID 21992066.
- Butler, John M. (2010). Fundamentals of forensic DNA typing. Burlington, MA: Elsevier/Academic Press. ISBN 9780080961767.
- Kidd, KK; Pakstis, AJ; Speed, WC; Grigorenko, EL; Kajuna, SL; Karoma, NJ; Kungulilo, S; Kim, JJ; Lu, RB; Odunsi, A; Okonofua, F; Parnas, J; Schulz, LO; Zhukova, OV; Kidd, JR (1 December 2006). "Developing a SNP panel for forensic identification of individuals". Forensic Science International. 164 (1): 20–32. doi:10.1016/j.forsciint.2005.11.017. PMID 16360294.
- Budowle, B; van Daal, A (April 2008). "Forensically relevant SNP classes". BioTechniques. 44 (5): 603–8, 610. doi:10.2144/000112806. PMID 18474034.
- Goldstein, J. A. (2001). "Clinical relevance of genetic polymorphisms in the human CYP2C subfamily". British Journal of Clinical Pharmacology. 52 (4): 349–355. doi:10.1046/j.0306-5251.2001.01499.x. PMC 2014584. PMID 11678778.
- Lee, C. R. (July–August 2004). "CYP2C9 genotype as a predictor of drug disposition in humans". Methods and findings in experimental and clinical pharmacology. 26 (6): 463–472. PMID 15349140.
- Yanase, K.; Tsukahara, S.; Mitsuhashi, J.; Sugimoto, Y. (8 March 2006). "Functional SNPs of the breast cancer resistance protein ‐ therapeutic effects and inhibitor development". Cancer Letters. 234 (1): 73–80. doi:10.1016/j.canlet.2005.04.039. PMID 16303243.
- Fareed, M.; Afzal, M. (April 2013). "Single-nucleotide polymorphism in genome-wide association of human population: A tool for broad spectrum service". Egyptian Journal of Medical Human Genetics. 14 (2): 123–134. doi:10.1016/j.ejmhg.2012.08.001.
- Singh, Monica; Singh, Puneetpal; Juneja, Pawan Kumar; Singh, Surinder; Kaur, Taranpal (2010). "SNP–SNP interactions within APOE gene influence plasma lipids in postmenopausal osteoporosis". Rheumatology International. 31 (3): 421–3. doi:10.1007/s00296-010-1449-7. PMID 20340021.
- Rees, A; Shoulders, CC; Galton, DJ; Baralle, FE (1983). "DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia". Lancet. 321 (8322): 444–446. PMID 6131168.
- Li, G.; Pan, T.One of the earliest successes in this field was finding a single base mutation in the non-coding region of the APOC3 (apolipoprotein C3 gene) that associated with higher risks of hypertriglyceridemia and atherosclerosis (see David J Galton Lancet 1983 pp444-446).; Guo, D.; Li, L. C. (2014). "Regulatory Variants and Disease: The E-Cadherin -160C/A SNP as an Example". Mol Biol Int. 2014: 967565. doi:10.1155/2014/967565. PMC 4167656. PMID 25276428.
- Lu, Yi-Fan; Mauger, David M.; Goldstein, David B.; Urban, Thomas J.; Weeks, Kevin M.; Bradrick, Shelton S. (4 November 2015). "IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearance". Scientific Reports. 5: 16037. doi:10.1038/srep16037. PMC 4631997. PMID 26531896.
- Kimchi-Sarfaty, C.; Oh, JM.; Kim, IW.; Sauna, ZE.; Calcagno, AM.; Ambudkar, SV.; Gottesman, MM. (Jan 2007). "A "silent" polymorphism in the MDR1 gene changes substrate specificity". Science. 315 (5811): 525–8. doi:10.1126/science.1135308. PMID 17185560.
- Al-Haggar M; Madej-Pilarczyk A; Kozlowski L; Bujnicki JM; Yahia S; Abdel-Hadi D; Shams A; Ahmad N; Hamed S; Puzianowska-Kuznicka M (2012). "A novel homozygous p.Arg527Leu LMNA mutation in two unrelated Egyptian families causes overlapping mandibuloacral dysplasia and progeria syndrome". Eur J Hum Genet. 20 (11): 1134–40. doi:10.1038/ejhg.2012.77. PMC 3476705. PMID 22549407. Archived from the original on 2015-11-16.
- Cordovado, SK.; Hendrix, M.; Greene, CN.; Mochal, S.; Earley, MC.; Farrell, PM.; Kharrazi, M.; Hannon, WH.; Mueller, PW. (Feb 2012). "CFTR mutation analysis and haplotype associations in CF patients". Mol Genet Metab. 105 (2): 249–54. doi:10.1016/j.ymgme.2011.10.013. PMC 3551260. PMID 22137130.
- Giegling I; Hartmann AM; Möller HJ; Rujescu D (November 2006). "Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene". Journal of Affective Disorders. 96 (1–2): 75–81. doi:10.1016/j.jad.2006.05.016. PMID 16814396.
- Kujovich, J. L. (Jan 2011). "Factor V Leiden thrombophilia". Genet Med. 13 (1): 1–16. doi:10.1097/GIM.0b013e3181faa0f2. PMID 21116184.
- Morita, Akihiko; Nakayama, Tomohiro; Doba, Nobutaka; Hinohara, Shigeaki; Mizutani, Tomohiko; Soma, Masayoshi (2007). "Genotyping of triallelic SNPs using TaqMan PCR". Molecular and Cellular Probes. 21 (3): 171–6. doi:10.1016/j.mcp.2006.10.005. PMID 17161935.
- Prodi, D.A.; Drayna, D; Forabosco, P; Palmas, MA; Maestrale, GB; Piras, D; Pirastu, M; Angius, A (2004). "Bitter Taste Study in a Sardinian Genetic Isolate Supports the Association of Phenylthiocarbamide Sensitivity to the TAS2R38 Bitter Receptor Gene". Chemical Senses. 29 (8): 697–702. doi:10.1093/chemse/bjh074. PMID 15466815.
- Ammitzbøll, Christian Gytz; Kjær, Troels Rønn; Steffensen, Rudi; Stengaard-Pedersen, Kristian; Nielsen, Hans Jørgen; Thiel, Steffen; Bøgsted, Martin; Jensenius, Jens Christian (28 November 2012). "Non-Synonymous Polymorphisms in the FCN1 Gene Determine Ligand-Binding Ability and Serum Levels of M-Ficolin". PLoS ONE. 7 (11): e50585. doi:10.1371/journal.pone.0050585. PMC 3509001. PMID 23209787. Archived from the original on 7 June 2015.
- Ji G, Long Y, Zhou Y, Huang C, Gu A, Wang X (2012). "Common variants in mismatch repair genes associated with increased risk of sperm DNA damage and male infertility". BMC Med. 10: 49. doi:10.1186/1741-7015-10-49. PMC 3378460. PMID 22594646.
- National Center for Biotechnology Information, United States National Library of Medicine. 2014. NCBI dbSNP build 142 for human. "Archived copy". Archived from the original on 2017-09-10. Retrieved 2017-09-11.CS1 maint: Archived copy as title (link)
- National Center for Biotechnology Information, United States National Library of Medicine. 2015. NCBI dbSNP build 144 for human. Summary Page. "Archived copy". Archived from the original on 2017-09-10. Retrieved 2017-09-11.CS1 maint: Archived copy as title (link)
- Glusman, G; Caballero, J; Mauldin, D. E.; Hood, L; Roach, J. C. (2011). "Kaviar: An accessible system for testing SNV novelty". Bioinformatics. 27 (22): 3216–7. doi:10.1093/bioinformatics/btr540. PMC 3208392. PMID 21965822.
- Cao, R; Shi, Y; Chen, S; Ma, Y; Chen, J; Yang, J; Chen, G; Shi, T (29 November 2016). "dbSAP: single amino-acid polymorphism database for protein variation detection". Nucleic Acids Research. 45: D827–D832. doi:10.1093/nar/gkw1096. PMC 5210569. PMID 27903894.
- Sachidanandam, R.; Weissman, D.; Schmidt, S. C.; Kakol, J. M.; Stein, L. D.; Marth, G.; Sherry, S.; Mullikin, J. C.; Mortimore, B. J.; Willey, D. L.; Hunt, S. E.; Cole, C. G.; Coggill, P. C.; Rice, C. M.; Ning, Z.; Rogers, J.; Bentley, D. R.; Kwok, P. Y.; Mardis, E. R.; Yeh, R. T.; Schultz, B.; Cook, L.; Davenport, R.; Dante, M.; Fulton, L.; Hillier, L.; Waterston, R. H.; McPherson, J. D.; Gilman, B.; Schaffner, S. (2001). "A map of human genome sequence variation containing 1.42 million single-nucleotide polymorphisms". Nature. 409 (6822): 928–933. doi:10.1038/35057149. PMID 11237013.
- J.T. Den Dunnen (2008-02-20). "Recommendations for the description of sequence variants". Human Genome Variation Society. Archived from the original on 2008-09-14. Retrieved 2008-09-05.
- den Dunnen, Johan T.; Antonarakis, Stylianos E. (2000). "Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion". Human Mutation. 15 (1): 7–12. doi:10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N. PMID 10612815.
- Ogino, Shuji; Gulley, Margaret L.; Den Dunnen, Johan T.; Wilson, Robert B.; Association for Molecular Pathology Training and Education Committee (2007). "Standard Mutation Nomenclature in Molecular Diagnostics Practical and Educational Challenges". The Journal of Molecular Diagnostics. 9 (1): 1–6. doi:10.2353/jmoldx.2007.060081. PMC 1867422. PMID 17251329.
- Sachidanandam, Ravi; Weissman, David; Schmidt, Steven C.; Kakol, Jerzy M.; Stein, Lincoln D.; Marth, Gabor; Sherry, Steve; Mullikin, James C.; et al. (2001). "A map of human genome sequence variation containing 1.42 million single-nucleotide polymorphisms". Nature. 409 (6822): 928–33. doi:10.1038/35057149. PMID 11237013.
- Altshuler, D; Pollara, V J; Cowles, C R; Van Etten, W J; Baldwin, J; Linton, L; Lander, E S (2000). "An SNP map of the human genome generated by reduced representation shotgun sequencing". Nature. 407 (6803): 513–6. doi:10.1038/35035083. PMID 11029002.
- Drabovich, A.P.; Krylov, S.N. (2006). "Identification of base pairs in single-nucleotide polymorphisms by MutS protein-mediated capillary electrophoresis". Analytical Chemistry. 78 (6): 2035–8. doi:10.1021/ac0520386. PMID 16536443.
- Griffin, T J; Smith, L M (2000). "Genetic identification by mass spectrometric analysis of single-nucleotide polymorphisms: ternary encoding of genotypes". Analytical Chemistry. 72 (14): 3298–302. doi:10.1021/ac991390e. PMID 10939403.
- Tahira, T.; Kukita, Y.; Higasa, K.; Okazaki, Y.; Yoshinaga, A.; Hayashi, K. (2009). "Estimation of SNP allele frequencies by SSCP analysis of pooled DNA". Methods Mol Biol. Methods in Molecular Biology. 578: 193–207. doi:10.1007/978-1-60327-411-1_12. ISBN 978-1-60327-410-4. PMID 19768595.
- "View of SNPViz - Visualization of SNPs in proteins". genomicscomputbiol.org. Retrieved 2018-10-20.
|Wikimedia Commons has media related to Single-nucleotide polymorphism.|
- NCBI resources – Introduction to SNPs from NCBI
- The SNP Consortium LTD – SNP search
- NCBI dbSNP database – "a central repository for both single base nucleotide substitutions and short deletion and insertion polymorphisms"
- HGMD – the Human Gene Mutation Database, includes rare mutations and functional SNPs
- GWAS Central – a central database of summary-level genetic association findings
- 1000 Genomes Project – A Deep Catalog of Human Genetic Variation
- WatCut – an online tool for the design of SNP-RFLP assays
- SNPStats – SNPStats, a web tool for analysis of genetic association studies
- Restriction HomePage – a set of tools for DNA restriction and SNP detection, including design of mutagenic primers
- American Association for Cancer Research Cancer Concepts Factsheet on SNPs
- PharmGKB – The Pharmacogenetics and Pharmacogenomics Knowledge Base, a resource for SNPs associated with drug response and disease outcomes.
- GEN-SNiP – Online tool that identifies polymorphisms in test DNA sequences.
- Rules for Nomenclature of Genes, Genetic Markers, Alleles, and Mutations in Mouse and Rat
- HGNC Guidelines for Human Gene Nomenclature
- SNP effect predictor with galaxy integration
- Open SNP – a portal for sharing own SNP test results
- dbSAP – SNP database for protein variation detection